MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
Suggest Documents
Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: a phase II trial.
Immunocytochemical determination of epidermal growth factor receptor with monoclonal EGFR1 antibody in primary breast cancer patients.
Management of dermatologic toxicities associated with monoclonal antibody epidermal growth factor receptor inhibitors: A case review.
Targeted therapy of solid tumors by monoclonal antibody specific to epidermal growth factor receptor.
Generation and Characterization of Rat Monoclonal Antibodies Against Epidermal Growth Factor Receptor.
Monoclonal antibody-conjugated superparamagnetic iron oxide nanoparticles for imaging of epidermal growth factor receptor-targeted cells and gliomas.
Nimotuzumab, a novel monoclonal antibody to the epidermal growth factor receptor, in the treatment of non-small cell lung cancer.
Anti-HER3 monoclonal antibody patritumab sensitizes refractory non-small cell lung cancer to the epidermal growth factor receptor inhibitor erlotinib.
Epidermal growth factor receptor in pancreatic cancer.
receptor in ovarian cancer cells.
Potential prognostic and diagnostic application of a novel monoclonal antibody against keratinocyte growth factor receptor.
Gastric carcinoma, epidermal growth factor, and epidermal growth factor receptor.
Epidermal growth factor receptor-directed monoclonal antibodies in nonsmall cell lung cancer: an update.
Anti-epidermal growth factor receptor monoclonal antibodies in metastatic colorectal cancer: a meta-analysis.
or epidermal growth factor receptor for the treatment of unresectable metastatic colorectal cancer.
Anti-epidermal growth factor receptor monoclonal antibodies as potential anti-cancer agents.
Population pharmacokinetics of rilotumumab, a fully human monoclonal antibody against hepatocyte growth factor, in cancer patients.
Biomarkers of skin toxicity induced by anti-epidermal growth factor receptor antibody treatment in colorectal cancer.
Oncogenic fingerprint of epidermal growth factor receptor pathway and emerging epidermal growth factor receptor blockade resistance in colorectal cancer.
Modulation of tyrosine, serine, and threonine phosphorylation and intracellular processing of the epidermal growth factor receptor by antireceptor monoclonal antibody.
Cytokine regulation by epidermal growth factor receptor inhibitors and epidermal growth factor receptor inhibitor associated skin toxicity in cancer patients.
Iodine-125-labeled anti-epidermal growth factor receptor-425 in the treatment of glioblastoma multiforme. A pilot study.
Significance of epidermal growth factor receptor in advanced ovarian cancer.
High affinity nanobodies against human epidermal growth factor receptor selected on cells by E. coli display.
Radiotoxicity of 125I-labeled monoclonal antibody 425 against cancer cells containing epidermal growth factor receptor.
Radiotoxicity of 125I-labeled monoclonal antibody 425 against cancer cells containing epidermal growth factor receptor. - PDF Download Free
514KB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: a phase II trial.
Immunocytochemical determination of epidermal growth factor receptor with monoclonal EGFR1 antibody in primary breast cancer patients.
Management of dermatologic toxicities associated with monoclonal antibody epidermal growth factor receptor inhibitors: A case review.
Targeted therapy of solid tumors by monoclonal antibody specific to epidermal growth factor receptor.
Generation and Characterization of Rat Monoclonal Antibodies Against Epidermal Growth Factor Receptor.
Monoclonal antibody-conjugated superparamagnetic iron oxide nanoparticles for imaging of epidermal growth factor receptor-targeted cells and gliomas.
Nimotuzumab, a novel monoclonal antibody to the epidermal growth factor receptor, in the treatment of non-small cell lung cancer.
Anti-HER3 monoclonal antibody patritumab sensitizes refractory non-small cell lung cancer to the epidermal growth factor receptor inhibitor erlotinib.
Epidermal growth factor receptor in pancreatic cancer.
receptor in ovarian cancer cells.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms